Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis

NCT02784106 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Placebo
DRUG: M2951
DRUG: M2951

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]